NEW DELHI — Park Medi World Limited, one of North India’s largest private hospital chains, has launched its Initial Public Offering (Park Medi World IPO), seeking to raise a substantial corpus from the primary market to fuel its next phase of growth and reduce debt. The IPO, which closes today, December 12, 2025, has attracted significant interest from investors looking to tap into India’s expanding healthcare sector.
Here is a detailed breakdown of the Park Medi World IPO, the company’s profile, financial health, and the key risks and opportunities for potential investors.
Table of Contents
Key Park Medi World IPO Details
Park Medi World IPO offering is a book-built issue of ₹920 crore, which is a mix of fresh equity shares and an Offer for Sale (OFS) by the promoter.
| Particular | Details |
| IPO Open & Close Date | December 10, 2025 – December 12, 2025 (Closes Today) |
| Price Band | ₹154 to ₹162 per equity share |
| Total Issue Size | ₹920 Crore |
| Issue Type | Fresh Issue (₹770 Cr) + Offer for Sale (₹150 Cr) |
| Retail Lot Size (Min) | 92 shares (₹14,904 at the upper band) |
| Allotment Finalisation | December 15, 2025 (Tentative) |
| Listing Date | December 17, 2025 (Tentative) |
| Exchanges | BSE and NSE |
Company Overview: A Regional Healthcare Giant
Founded in 2011, Park Medi World IPO operates under the ‘Park’ brand and has established a dominant regional presence.
- Network: It is the second-largest private hospital chain in North India and the largest in Haryana by bed capacity.
- Capacity: The company manages 14 multi-super specialty hospitals with an aggregate capacity of approximately 3,000 beds (as of March 2025), with expansion plans to reach nearly 4,900 beds by FY28.
- Accreditations: All its hospitals are NABH-accredited, with several also holding NABL accreditation, signifying a focus on high-quality standards.
- Specialties: Services span over 30 specialities, including high-demand areas like oncology, neurology, gastroenterology, and orthopaedics.
Use of IPO Proceeds
The funds from the fresh issue portion (₹770 Cr) are earmarked for strategic goals that will stabilize the balance sheet and accelerate expansion:
- Debt Reduction: Approximately ₹380 crore will be used for the repayment or prepayment of outstanding borrowings, which will reduce interest costs and improve the debt-to-equity ratio.
- Capital Expenditure: Funds will be invested in the development of a new hospital in NCR (under Park Medicity) and the expansion of existing facilities.
- Equipment & Acquisitions: Allocation for purchasing medical equipment and pursuing future inorganic growth opportunities (acquisitions).
Financial Performance & Valuation
The company has demonstrated robust growth in profitability recently:
| Particulars (₹ in Crores) | FY2023 | FY2024 | FY2025 |
| Total Income | 1,272.18 | 1,263.08 | 1,425.97 |
| Profit After Tax (PAT) | 228.19 | 152.01 | 213.22 |
| EBITDA Margin (%) | 31.1% | 24.6% | 26.7% |
- Valuation: At the upper end of the price band (₹162), the company is valued at a Post-Park Medi World IPO P/E ratio of approximately 32.8x (based on FY25 earnings). Analysts note this is at a discount compared to some listed peers whose P/E ratios are significantly higher (e.g., in the 40x to 70x range), making the IPO appear attractively priced to many.
Park Medi World IPO Investor Takeaways: Strengths vs. Risks
Key Strengths
- Regional Dominance: Strong leadership position in the high-growth Haryana market.
- Acquisition-led Growth: Proven track record of expanding rapidly through strategic hospital acquisitions, offering a lower average cost per bed.
- Steady Business Mix: A large portion of revenue comes from government schemes and PSUs, ensuring a stable volume of patient footfall.
Key Risks
- Geographic Concentration: A high dependence on revenue from hospitals in Haryana (historically 70%+), making it vulnerable to regional policy changes.
- Inconsistent Occupancy: Bed occupancy rates have fluctuated, indicating under-utilization of capacity in certain periods.
- Talent Dependency: Like all hospital chains, its performance is tied to its ability to attract and retain key doctors and skilled medical staff.
Subscription Status Note: As of the final day of bidding, the issue is generally fully subscribed, with strong interest from the Retail and Non-Institutional Investor (NII) segments. Age Calculator